OK Biotech Co., Ltd. (TPE:4155)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Patient Monitoring Equipment			1.21B	1.49B	1.27B	1.50B	1.25B
Patient Monitoring Equipment Growth			-19.08%	17.88%	-15.31%	19.46%	11.21%
Intersegment Revenue			-16.37M	-9.78M	-3.40M	-11.29M	-10.77M
Total			1.19B	1.48B	1.26B	1.48B	1.24B
Total Growth			-19.65%	17.43%	-14.89%	19.59%	10.79%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Asia			401.62M	387.70M	509.90M	474.41M	531.70M
Asia Growth			3.59%	-23.97%	7.48%	-10.78%	16.88%
Internal Departmental Transaction			-16.37M	-9.78M	-3.40M	-11.29M	-10.77M
Africa			222.48M	342.00M	101.52M	446.04M	126.63M
Africa Growth			-34.95%	236.90%	-77.24%	252.24%	-
Europe			113.80M	67.41M	79.97M	65.33M	54.82M
Europe Growth			68.83%	-15.71%	22.41%	19.18%	-
America			373.34M	608.45M	505.58M	426.61M	415.67M
America Growth			-38.64%	20.35%	18.51%	2.63%	24.33%
Taiwan			97.11M	87.73M	69.69M	83.19M	84.12M
Taiwan Growth			10.69%	25.89%	-16.23%	-1.10%	104.17%
Others			-	-	124.00K	118.00K	39.08M
Others Growth			-	-	5.08%	-99.70%	-86.77%
Total			1.19B	1.48B	1.26B	1.48B	1.24B
Total Growth			-19.65%	17.43%	-14.89%	19.59%	10.79%

Source: S&P Global Market Intelligence.